Ignite Creation Date:
2024-05-05 @ 10:45 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01176799
Status:
UNKNOWN
Last Update Posted:
2016-06-22
First Post:
2010-08-05
Brief Title:
Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor
Sponsor:
National University Hospital Singapore
Organization:
National University Hospital Singapore
Organization Data
Organization:
National University Hospital Singapore
Class:
OTHER
Study ID:
BR010910
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National University Hospital Singapore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None